JP2009544688A5 - - Google Patents

Download PDF

Info

Publication number
JP2009544688A5
JP2009544688A5 JP2009521380A JP2009521380A JP2009544688A5 JP 2009544688 A5 JP2009544688 A5 JP 2009544688A5 JP 2009521380 A JP2009521380 A JP 2009521380A JP 2009521380 A JP2009521380 A JP 2009521380A JP 2009544688 A5 JP2009544688 A5 JP 2009544688A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
fusion polypeptide
phospholipase
ptd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009521380A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544688A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2007/003404 external-priority patent/WO2008015580A2/en
Publication of JP2009544688A publication Critical patent/JP2009544688A/ja
Publication of JP2009544688A5 publication Critical patent/JP2009544688A5/ja
Pending legal-status Critical Current

Links

JP2009521380A 2006-07-24 2007-07-19 虚血性疾患の緩和及び治療のための医薬組成物並びにそれを伝達するための方法 Pending JP2009544688A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83258406P 2006-07-24 2006-07-24
PCT/IB2007/003404 WO2008015580A2 (en) 2006-07-24 2007-07-19 Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same

Publications (2)

Publication Number Publication Date
JP2009544688A JP2009544688A (ja) 2009-12-17
JP2009544688A5 true JP2009544688A5 (cg-RX-API-DMAC10.html) 2010-08-05

Family

ID=38997534

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009521380A Pending JP2009544688A (ja) 2006-07-24 2007-07-19 虚血性疾患の緩和及び治療のための医薬組成物並びにそれを伝達するための方法

Country Status (6)

Country Link
US (1) US7902154B2 (cg-RX-API-DMAC10.html)
EP (1) EP2044108A4 (cg-RX-API-DMAC10.html)
JP (1) JP2009544688A (cg-RX-API-DMAC10.html)
KR (1) KR101574630B1 (cg-RX-API-DMAC10.html)
CN (1) CN101490080A (cg-RX-API-DMAC10.html)
WO (1) WO2008015580A2 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9416383B2 (en) * 2007-04-27 2016-08-16 University Of North Carolina At Chapel Hill Method for enhancing catalytic activity of a lipase
US7981446B2 (en) * 2007-11-26 2011-07-19 Forhumantech. Co., Ltd. Pharmaceutical compositions and methods for delivering nucleic acids into cells
CN101612384B (zh) * 2009-07-23 2012-06-20 中国人民解放军第二军医大学 多肽小分子mlif在制备防治心肌缺血药物中的应用
KR101278221B1 (ko) * 2010-06-01 2013-06-24 연세대학교 산학협력단 Ρtd-uqcrb 융합 폴리펩타이드 및 그를 포함하는 허혈성 질환의 예방 및 치료용 약제학적 조성물
CN104507961B (zh) 2012-05-11 2018-08-14 珍白斯凯尔有限公司 抗炎性肽及包含其的组合物
EP2875826B1 (en) 2012-05-11 2017-08-23 KAEL-GemVax Co.,Ltd Composition for preventing or treating sepsis
WO2014010971A1 (ko) 2012-07-11 2014-01-16 주식회사 카엘젬백스 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
KR102258864B1 (ko) 2013-04-19 2021-06-01 주식회사 젬백스앤카엘 허혈성 손상 치료 및 예방용 조성물
AU2014275610B2 (en) 2013-06-07 2018-06-14 Gemvax & Kael Co., Ltd. Biological markers useful in cancer immunotherapy
ES2808076T3 (es) 2013-06-21 2021-02-25 Gemvax & Kael Co Ltd Regulador de la secreción hormonal, composición que lo contiene y procedimiento para controlar la secreción hormonal mediante su uso
KR102359396B1 (ko) 2013-11-22 2022-02-08 주식회사 젬백스앤카엘 혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
JP6367950B2 (ja) 2013-12-17 2018-08-01 ジェムバックス アンド カエル カンパニー,リミティド 前立腺癌治療用組成物
ES2908096T3 (es) 2014-04-11 2022-04-27 Gemvax & Kael Co Ltd Péptido con actividad inhibidora de la fibrosis y composición que lo contiene
WO2015167067A1 (ko) * 2014-04-30 2015-11-05 주식회사 카엘젬백스 장기, 조직 또는 세포 이식용 조성물, 키트 및 이식 방법
WO2015170790A1 (ko) * 2014-05-09 2015-11-12 주식회사 카엘젬백스 허혈성 손상 치료 및 예방용 조성물
KR102413243B1 (ko) 2014-12-23 2022-06-27 주식회사 젬백스앤카엘 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
US10835582B2 (en) 2015-02-27 2020-11-17 Gemvax & Kael Co. Ltd. Peptide for preventing hearing loss, and composition comprising same
JP6923453B2 (ja) 2015-07-02 2021-08-18 ジェムバックス アンド カエル カンパニー,リミティド 抗ウイルス活性効能を有するペプチド及びこれを含む組成物
ES2949697T3 (es) 2016-04-07 2023-10-02 Gemvax & Kael Co Ltd Péptido que tiene efectos de aumento de la actividad telomerasa y de extensión de los telómeros, y composición que contienen el mismo
KR20250057224A (ko) 2023-10-19 2025-04-29 단국대학교 천안캠퍼스 산학협력단 Pdrn을 이용한 유치줄기세포를 포함하는 세포치료제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0920508A1 (en) 1996-08-23 1999-06-09 Chiron Corporation HUMAN POLYHOMEOTIC 1 ($i(hph1)) ACTS AS AN ONCOGENE
US20030104622A1 (en) 1999-09-01 2003-06-05 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
GB0103110D0 (en) * 2000-08-25 2001-03-28 Aventis Pharma Inc A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1
KR20030062788A (ko) 2002-01-19 2003-07-28 포휴먼텍(주) 생체분자 전달 펩타이드 mph1-btm 및 이것을포함하는 생명공학제품
KR20030062789A (ko) 2002-01-19 2003-07-28 포휴먼텍(주) 생체분자 전달 펩타이드 sim2-btm 및 이것을포함하는 생명공학제품
KR100591936B1 (ko) 2002-11-12 2006-06-22 포휴먼텍(주) 세포내 dna/rna 전달 방법, 및 이것의 기초 및임상학적 응용
US7166692B2 (en) * 2003-03-04 2007-01-23 Canbrex Bio Science Walkersville, Inc. Intracellular delivery of small molecules, proteins, and nucleic acids
EP3167935B1 (en) 2003-05-01 2018-07-18 Cornell Research Foundation, Inc. Method and carrier complexes for delivering molecules to cells
US7339042B2 (en) * 2003-06-09 2008-03-04 University Of Florida Research Foundation, Inc. Gene delivery to tumors
ATE478676T1 (de) 2005-11-04 2010-09-15 Forhumantech Co Ltd Verfahren zur abgabe von fusionspolypeptid in eine zelle
EP2057195A4 (en) 2006-08-29 2010-05-12 Forhumantech Co Ltd PHARMACEUTICAL COMPOSITION FOR THE SUPPRESSION OF APOPTOSIS AND METHOD OF ADMINISTERING THE SAME

Similar Documents

Publication Publication Date Title
RU2582247C2 (ru) Ингибиторы апоптоза и их применение
Shoshan-Barmatz et al. The Voltage-dependent Anion Channel in Endoplasmic/Sarcoplasmic Reticulum: Characterization, Modulation and Possible Function: V. Shoshan-Barmatz and A. Israelson
US9707268B2 (en) Angiotensin type 2 (AT2) receptor agonists and uses thereof
JP3473623B2 (ja) うっ血性心不全を治療するための、成長ホルモンとインスリン様成長因子との組み合わせ
JP2023528204A5 (cg-RX-API-DMAC10.html)
CN110114065A (zh) 通过甲状旁腺激素受体刺激进行的骨折靶向性骨再生
WO2016118577A1 (en) Thymosin-beta-four fusion proteins
HUP0303763A2 (hu) A trombinnal aktiválható fibrinolízist gátló (TAFIa-gátló) szubsztituált imidazolok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
US20200399333A1 (en) Histatins and method of use thereof
KR101746749B1 (ko) 뇌졸중-유발된 혈관신생 증진제 및 이의 용도
EA201791668A1 (ru) Синтетические конъюгаты апелина с жирной кислотой с улучшенным периодом полураспада
US20160168210A1 (en) Derivatives of collagen-binding hairpin peptides
JP2025521751A (ja) コラーゲンペプチドベースの医薬組成物及びその使用
CN106063928B (zh) 一种多肽或其衍生物在治疗高血压性心肌肥厚中的应用
Lee et al. Human erythropoietin gene delivery for cardiac remodeling of myocardial infarction in rats
EP3716993A1 (en) Treatment of an ischemic heart disease
JP2025510591A5 (cg-RX-API-DMAC10.html)
JP2025522281A (ja) Cnp化合物の液体医薬製剤
JP2023549323A5 (cg-RX-API-DMAC10.html)
US20260085101A1 (en) Novel platelet derived growth factor peptide mimetic
CN112390877B (zh) Pedf衍生多肽组合物及其在制备保护肺损伤药物中的应用
KR20260038341A (ko) 콜라겐 혼성화 펩타이드로 표면개질된 심근세포 및 이의 용도
HK40105081A (en) Peptides with antimicrobial activities
RU2454425C2 (ru) Производные метастина и их применение
Monden AAAAA SD